Perrigo Ordinary Shares reported $749.6M in Cost of Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Abbott ABT:US $ 4933M 54M
Abbvie ABBV:US $ 4142M 121M
Bayer BAYN:GR € 5680M 504M
Bristol Myers Squibb BMY:US $ 2677M 206M
Catalent CTLT:US $ 850M 38M
Coherus Biosciences CHRS:US $ 11.28M 1.91M
Corcept Therapeutics CORT:US $ 1.32M 0.07M
Dr.Reddys Laboratories DRRD:IN 19.11B 135M
Eli Lilly And LLY:US $ 1430.5M 641.6M
Endo International Ordinary Shares ENDP:US $ 263.79M 84.03M
Horizon Pharma HZNP:US $ 230.22M 15.15M
JAZZ PHA JAZZ:US $ 124.21M 8.92M
Johnson & Johnson JNJ:US $ 7919M 321M
Lannett LCI:US $ 75.28M 5.52M
Merk MRK:US $ 3698M 1636M
Pacira Pharmaceuticals PCRX:US $ 50.63M 14.55M
Perrigo Ordinary Shares PRGO:US $ 749.6M 12.9M
Pfizer PFE:US $ 8671M 1339M
Phibro Animal Health PAHC:US $ 167.99M 5.95M
Prestige Brands PBH:US $ 116.94M 1.13M
Supernus Pharmaceuticals SUPN:US $ 20.46M 2.52M
Teva Pharmaceutical TEVA:IT 1.96B 99M
Xeris Pharmaceuticals Inc XERS:US $ 4.81M 1.46M
Zoetis ZTS:US $ 620M 55M